Trombophilia

neuroophthalmological manifestation

Authors

  • Sol M. Kovalivker Centro de Ojos Quilmes, Quilmes, Buenos Aires, Argentina
  • Constanza Bonavita Centro de Ojos Quilmes, Quilmes, Buenos Aires, Argentina
  • Florencia Passarelli Centro de Ojos Quilmes, Quilmes, Buenos Aires, Argentina
  • Lidia Sarotto Hospital de Clínicas "José de San Martín"
  • M. Laura Braccia Gancedo Hospital de Clínicas "José de San Martín"
  • Luciana L. Iacono Hospital de Clínicas "José de San Martín"

DOI:

https://doi.org/10.70313/2718.7446.v16.n03.248

Keywords:

thrombophilia, papilledema, cerebral venous sinus thrombosis, intracanial hypertension, thrombogenesis, neurooftalmology

Abstract

Objective: Report on a form of thrombophilia from the clinical case of a patient with papilledema caused by 2 cerebral venous sinus thrombosis, product of such disease.

Case report: 47-year-old female patient who presented to the ophthalmology ER reporting episodes of transient darkening of vision, severe headache and tinnitus. During the ophthalmologic examination she had evidence of bilateral papilledema, showing cerebral venous sinus thrombosis during the magnetic resonance angiography as a first instance pathophysiological factor. After thourough clinical and lab exams, thrombophilia diagnosis is confirmed as the cause for the cerebral venous sinus thrombosis, and so she was treated with anticoagulants showing a remarkable improvement in the clinical scenario.

Conclusion: This case highlights that thrombophilia can be a cause of cerebral venous sinus thrombosis, also causing bilateral papilledema.

Downloads

Download data is not yet available.

Author Biography

  • Luciana L. Iacono, Hospital de Clínicas "José de San Martín"

    Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.

References

Saposnik G, Barinagarrementeria F, Brown RD Jr et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 1158-1192.

Medicherla CB, Pauley RA, de Havenon A et al. Cerebral venous sinus thrombosis in the Covid-19 pandemic. J Neuroophthalmol 2020; 40: 457-462.

Ferro JM, Canhão P, Stam J et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study of Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.

Duman T, Uluduz D, Midi I, VENOST Study Group et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis 2017; 26: 1848–1857.

Aaron S, Arthur A, Prabakhar AT, et al. Spectrum of visual impairment in cerebral venous thrombosis: importance of tailoring therapies based on pathophysiology. Ann Indian Acad Neurol 2017; 20: 294-301.

Altuna D, Ceresetto J, Fassi D et al. Trombofilias. Buenos Aires: Sociedad Argentina de Hematología, 2012, p. 471-481. Disponible en: http://www.sah.org.ar/docs/471-481.12.SAH_GUIA2012_Trombofilia.pdf

Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59:1492-1495.

Linn J, Brückmann H. Cerebral venous and dural sinus thrombosis: state-of-the-art imaging. Clin Neuroradiol 2010; 20: 25-37.

Brune AJ, Girgla T, Trobe JD. Complications of ventriculoperitoneal shunt for idiopathic intracranial hypertension: a single-institution study of 32 patients. J Neuroophthalmol 2021; 41: 224-232.

Published

2023-09-27

Issue

Section

Case Report

How to Cite

[1]
2023. Trombophilia: neuroophthalmological manifestation. Oftalmología Clínica y Experimental. 16, 3 (Sep. 2023), e296-e301. DOI:https://doi.org/10.70313/2718.7446.v16.n03.248.

Similar Articles

1-10 of 276

You may also start an advanced similarity search for this article.